AUS
NZ
UK
CA
USA
IND
Xero Limited (ASX:XRO) provides appendix 4D for the 6 months period ending 30 September 2018. The company discloses the details related to the revenues generated from ordinary activities worth NZ$256.527 million which is up by 37%. The net loss from ordinary activities after tax is NZ$28.565 million, which is up by 46%. The net loss attributable to security holders is NZ$28.565 million. During this period the company has not proposed any dividend and also no dividends are declared or paid for the reporting period. The net tangible asset per share at 30 September 2018 is NZ$0.54. During the period of 6 months the company also gained control on certain entities. The company gained control on Xero Acquisition I Limited from 24 July 2018. The company gained control on Hubdoc Inc, Hubdoc Pty Limited and 10914819 Canada Inc on 2 August 2018. On 17 September 2018, the company gained control on Xero Investments Limited.Â
On 16 August 2018, Xero Acquisition I Limited, and 10914819 Canada Inc. were merged with Hubdoc Inc.
For the half yearly period ended 30 September 2018, total revenue from operations is $256.527 million. The total asset of the company is $996.383 million. The total liabilities of the company is $666.818 million. This indicates that the company is able to meet its long term obligations. The total current assets of the company is $658.144million and total current liabilities is $159.894 million. This indicates that the company is able to meet the working capital requirements as well as the short term obligations. The total shareholders equity is worth $329.565 million. The net cash inflow from the operating activities is $35.988 million. The major cash outflow was due to the payments made to suppliers and employees worth $217.675 million. The net cash outflows from investing activities $76.071 million. The major cash outflow was due to the development cost worth $33.516 million. The company made acquisition of Hubdoc worth $30.312. The company purchased property plant and equipment worth $6.939 million. The company also made payment for the contract acquisition costs worth $7.032 million. The net cash inflows from financing activities is worth $ 39.587 million. The major cash outflow was due to repayment of borrowings worth $0.733 million. The company made payment of lease liabilities worth $4.089 million. They also made payment for the short-term deposits worth $37 million. There was a net decrease in the cash and cash equivalent of $0.496 million. The net cash and cash equivalent at the end of the year was $21.187 million.
The performance of the company as of now since its inception is 859.15%. The one year and 5 years performance of the company is 37.02% and 50.56%. Today the share price of the company is $44.08 (AEST: 12:37 pm). There was an increase in the share price by 2.583% since morning which is equivalent to 1.110 points. The market capitalization is A$6.04 billion.
As per the chart, the moving average convergence and divergence line (MACD line) is moving above the signal line in the upwards direction. Also, as per the candlestick pattern, it appears that the buyers are a little exhausted and the sellers are becoming dominant.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
